{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T17:07:30Z","timestamp":1773335250861,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T00:00:00Z","timestamp":1630368000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009945","name":"Merck KGaA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009945","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.neo.2021.08.005","type":"journal-article","created":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T09:12:36Z","timestamp":1632733956000},"page":"1069-1077","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["RosettaSX: Reliable gene expression signature scoring of cancer models and patients"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1084-8481","authenticated-orcid":false,"given":"Julian","family":"Kreis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boro","family":"Nedi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna","family":"Mazur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Urban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven-Eric","family":"Schelhorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Grombacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Geist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedikt","family":"Brors","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Z\u00fchlsdorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eike","family":"Staub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neo.2021.08.005_bib0001","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/ng1434","article-title":"A module map showing conditional activity of expression modules in cancer","volume":"36","author":"Segal","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neo.2021.08.005_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13059-015-0620-6","article-title":"Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy","volume":"16","author":"Angelova","year":"2015","journal-title":"Genome Biol"},{"key":"10.1016\/j.neo.2021.08.005_bib0003","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/nrc1976","article-title":"Linking oncogenic pathways with therapeutic opportunities","volume":"6","author":"Bild","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.neo.2021.08.005_bib0004","doi-asserted-by":"crossref","first-page":"15449","DOI":"10.1073\/pnas.1004900107","article-title":"Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes","volume":"107","author":"Taube","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neo.2021.08.005_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-43492-0","article-title":"Analytical validation of multiplex biomarker assay to stratify colorectal cancer into molecular subtypes","volume":"9","author":"Ragulan","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neo.2021.08.005_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/bcr1517","article-title":"Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients","volume":"8","author":"Calza","year":"2006","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.neo.2021.08.005_bib0007","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1038\/sj.onc.1208561","article-title":"Identification of molecular apocrine breast tumours by microarray analysis","volume":"24","author":"Farmer","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.neo.2021.08.005_bib0008","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrc3774","article-title":"The tumour microenvironment in B cell lymphomas","volume":"14","author":"Scott","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.neo.2021.08.005_bib0009","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.neo.2021.08.005_bib0010","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/annonc\/mdt494","article-title":"Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone","volume":"25","author":"Gnant","year":"2014","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.neo.2021.08.005_bib0011","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nature11412","article-title":"Comprehensive molecular portraits of human breast tumours","volume":"490","author":"Koboldt","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.neo.2021.08.005_bib0012","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/sj.onc.1209778","article-title":"Serrated carcinomas form a subclass of colorectal cancer with distinct molecular basis","volume":"26","author":"Laiho","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.neo.2021.08.005_bib0013","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/bjc.2011.505","article-title":"Potential responders to FOLFOX therapy for colorectal cancer by Random Forests analysis","volume":"106","author":"Tsuji","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.neo.2021.08.005_bib0014","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1126\/science.1132939","article-title":"The connectivity map: Using gene-expression signatures to connect small molecules, genes, and disease","volume":"313","author":"Lamb","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.neo.2021.08.005_bib0015","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.drudis.2018.05.036","article-title":"Why breast cancer signatures are no better than random signatures explained","volume":"23","author":"Goh","year":"2018","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.neo.2021.08.005_bib0016","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1371\/journal.pcbi.1002240","article-title":"Most random gene expression signatures are significantly associated with breast cancer outcome","volume":"7","author":"Venet","year":"2011","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.neo.2021.08.005_bib0018","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/s41596-019-0136-8","article-title":"Guidelines for using sigQC for systematic evaluation of gene signatures","volume":"14","author":"Dhawan","year":"2019","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.neo.2021.08.005_bib0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/2354564","article-title":"Characteristics and validation techniques for PCA-based gene-expression signatures","volume":"2017","author":"Berglund","year":"2017","journal-title":"Int. J. Genomics"},{"key":"10.1016\/j.neo.2021.08.005_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2202\/1544-6115.1055","article-title":"Calculating the statistical significance of changes in pathway activity from gene expression data","volume":"3","author":"Rahnenf\u00fchrer","year":"2004","journal-title":"Stat. Appl. Genet. Mol. Biol."},{"key":"10.1016\/j.neo.2021.08.005_bib0021","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nmeth.3734","article-title":"Characterizing transcriptional heterogeneity through pathway and gene set overdispersion analysis","volume":"13","author":"Fan","year":"2016","journal-title":"Nat. Methods"},{"key":"10.1016\/j.neo.2021.08.005_bib0022","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1593\/tlo.12214","article-title":"An interferon response gene expression signature is activated in a subset of medulloblastomas","volume":"5","author":"Staub","year":"2012","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.neo.2021.08.005_bib0023","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.neo.2021.08.005_bib0024","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.1158\/0008-5472.CAN-08-3403","article-title":"Relationship of deregulated signaling converging onto mTOR with prognosis and classification of lung adenocarcinoma shown by two independent in silico analyses","volume":"69","author":"Ebi","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.neo.2021.08.005_bib0025","doi-asserted-by":"crossref","unstructured":"N. Harbeck, F. Penault-Llorca, J. Cortes, M. Gnant, N. Houssami, P. Poortmans, K. Ruddy, J. Tsang, F. Cardoso, Breast cancer, Nat. Rev. Dis. Primers, 5, (1), 2019, 66","DOI":"10.1038\/s41572-019-0111-2"},{"key":"10.1016\/j.neo.2021.08.005_bib0026","doi-asserted-by":"crossref","DOI":"10.1186\/s13104-019-4653-x","article-title":"Ki67 index in intrinsic breast cancer subtypes and its association with prognostic parameters","volume":"12","author":"Hashmi","year":"2019","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.neo.2021.08.005_bib0027","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Perou","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.neo.2021.08.005_bib0028","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41587-020-0550-z","article-title":"Overcoming barriers to early disease intervention","volume":"38","author":"Caicedo","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.neo.2021.08.005_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-15574-5","article-title":"Re-definition of claudin-low as a breast cancer phenotype","volume":"11","author":"Fougner","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neo.2021.08.005_bib0030","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1200\/JCO.2013.54.1870","article-title":"Luminal B breast cancer: Molecular characterization, clinical management, and future perspectives","volume":"32","author":"Ades","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.neo.2021.08.005_bib0031","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/modpathol.2013.153","article-title":"Distinguishing luminal breast cancer subtypes by Ki67, progesterone receptor or TP53 status provides prognostic information","volume":"27","author":"Feeley","year":"2014","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.neo.2021.08.005_bib0032","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1210\/me.2010-0164","article-title":"Minireview: basal-like breast cancer: from molecular profiles to targeted therapies","volume":"25","author":"Toft","year":"2011","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.neo.2021.08.005_bib0033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41523-018-0067-5","article-title":"TP53 protein levels, RNA-based pathway assessment, and race among invasive breast cancer cases","volume":"4","author":"Williams","year":"2018","journal-title":"npj Breast Cancer"},{"key":"10.1016\/j.neo.2021.08.005_bib0034","doi-asserted-by":"crossref","first-page":"13550","DOI":"10.1073\/pnas.0506230102","article-title":"An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival","volume":"102","author":"Miller","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neo.2021.08.005_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-6-276","article-title":"Gene expression patterns associated with p53 status in breast cancer","volume":"6","author":"Troester","year":"2006","journal-title":"BMC Cancer"},{"key":"10.1016\/j.neo.2021.08.005_bib0036","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/path.4212","article-title":"Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer","volume":"231","author":"Budinska","year":"2013","journal-title":"J. Pathol."},{"key":"10.1016\/j.neo.2021.08.005_bib0037","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The molecular signatures database hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"key":"10.1016\/j.neo.2021.08.005_bib0038","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1172\/JCI45014","article-title":"Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies","volume":"121","author":"Lehmann","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neo.2021.08.005_bib0039","doi-asserted-by":"crossref","first-page":"96","DOI":"10.2174\/156652412798376134","article-title":"Basal breast cancer: a complex and deadly molecular subtype","volume":"12","author":"Bertucci","year":"2011","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.neo.2021.08.005_bib0040","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1158\/1078-0432.CCR-11-2210","article-title":"A comprehensive analysis of human gene expression profiles identifies stromal immunoglobulin \u03ba C as a compatible prognostic marker in human solid tumors","volume":"18","author":"Schmidt","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neo.2021.08.005_bib0041","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2019.01497","article-title":"Identification of distinct immune subtypes in colorectal cancer based on the stromal compartment","volume":"9","author":"Shen","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.neo.2021.08.005_bib0042","doi-asserted-by":"crossref","first-page":"4869","DOI":"10.3892\/ol.2016.5369","article-title":"Biomarkers for EMT and MET in breast cancer: an update (review)","volume":"12","author":"Liu","year":"2016","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.neo.2021.08.005_bib0043","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s10549-018-05089-5","article-title":"Epithelial-to-mesenchymal transition status of primary breast carcinomas and its correlation with metastatic behavior","volume":"174","author":"Savci-Heijink","year":"2019","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.neo.2021.08.005_bib0044","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1038\/s41388-021-01719-3","article-title":"Stromal NRG1 in luminal breast cancer defines pro-fibrotic and migratory cancer-associated fibroblasts","volume":"40","author":"Berdiel-Acer","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.neo.2021.08.005_bib0045","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pathol.2019.08.013","article-title":"Diffuse large B-cell lymphoma variants: an update","volume":"52","author":"Sukswai","year":"2020","journal-title":"Pathology"},{"key":"10.1016\/j.neo.2021.08.005_bib0046","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nri3814","article-title":"Germinal centres and B cell lymphomagenesis","volume":"15","author":"Basso","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.neo.2021.08.005_bib0047","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity","volume":"483","author":"Barretina","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.neo.2021.08.005_bib0048","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1038\/ng.3984","article-title":"Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells","volume":"49","author":"Meyers","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neo.2021.08.005_bib0049","article-title":"Extracting biological insights from the project Achilles Genome-Scale CRISPR screens in cancer cell lines","author":"Dempster","year":"2019","journal-title":"bioRxiv"},{"key":"10.1016\/j.neo.2021.08.005_bib0050","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","article-title":"Next-generation characterization of the Cancer Cell Line Encyclopedia","volume":"569","author":"Ghandi","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.neo.2021.08.005_bib0051","article-title":"The UCSC Xena platform for cancer genomics data visualization and interpretation Paper Introduction","author":"Goldman","year":"2018","journal-title":"bioRxiv"},{"issue":"15","key":"10.1016\/j.neo.2021.08.005_bib52","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"The Molecular Signatures Database Hallmark Gene Set Collection","volume":"378","author":"Schmitz","year":"2018","journal-title":"N Engl J Med"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558621000750?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558621000750?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:08:58Z","timestamp":1761484138000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558621000750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":51,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S1476558621000750"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2021.08.005","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RosettaSX: Reliable gene expression signature scoring of cancer models and patients","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2021.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}